Role of different pf crt and pf mdr-1 mutations in conferring resistance to antimalaria drugs in plasmodium falciparum

Malaria Research and Treatment

Volumn 2014, Issue , 2014, Pages

  Ibraheem, Zaid O ^a   Abd Majid, R ^a   Noor, S Mohd ^a   Sedik, H Mohd ^b   Basir, R ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; AMODIAQUINE; BENFLUMETOL; CHLOROQUINE; CHLOROQUINE RESISTANCE TRANSPORTER PROTEIN; DIHYDROARTEMISININ; HALOFANTRINE; MEFLOQUINE; MEMBRANE PROTEIN; MULTIDRUG RESISTANCE TRANSPORTER PROTEIN; PHENANTHRENE DERIVATIVE; PIPERAQUINE; QUININE; QUINOLINE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANTIMALARIAL DRUG RESISTANCE; ARTICLE; CELL MEMBRANE; CELL VACUOLE; CELLULAR DISTRIBUTION; DRUG SENSITIVITY; ENZYME ACTIVE SITE; EPIDEMIOLOGICAL DATA; GENE AMPLIFICATION; GENE FREQUENCY; GENE MAPPING; GENE MUTATION; GENE OVEREXPRESSION; GENETIC TRAIT; GEOGRAPHIC DISTRIBUTION; GLYCOSYLATION; HAPLOTYPE; HYDROPHILICITY; HYDROPHOBICITY; ISOELECTRIC POINT; LIPOPHILICITY; MOLECULAR EVOLUTION; NONHUMAN; PHYSICAL CHEMISTRY; PLASMODIUM FALCIPARUM; POINT MUTATION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN FUNCTION; SINGLE NUCLEOTIDE POLYMORPHISM; UBIQUITINATION; VIRUS REPLICATION;

EID: 85018652853     PISSN: 20908075     EISSN: 20444362     Source Type: Journal    
DOI: 10.1155/2014/950424     Document Type: Article

References (99)

1. Boni M. F., Smith D. L., Laxminarayan R., Benefits of using multiple first-line therapies against malaria. Proceedings of the National Academy of Sciences of the United States of America 2008 105 37 14216 14221 10.1073/pnas.0804628105 2-s2.0-52949150087
2. Burrows J. N., Leroy D., Lotharius J., Waterson D., Challenges in antimalarial drug discovery. Future Medicinal Chemistry 2011 3 11 1401 1412 10.4155/fmc.11.91 2-s2.0-80052405122
3. Wootton J. C., Feng X., Ferdig M. T., Cooper R. A., Mu J., Baruch D. I., Magill A. J., Su X.-Z., Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature 2002 418 6895 320 323 10.1038/nature00813 2-s2.0-0037130254
4. Chan C. W., Spathis R., Reiff D. M., McGrath S. E., Garruto R. M., Lum J. K., Diversity of Plasmodium falciparum chloroquine resistance transporter (pfcrt) exon 2 haplotypes in the pacific from 1959 to 1979. PLoS ONE 2012 7 1 e30213 10.1371/journal.pone.0030213 2-s2.0-84855853686
5. Looareesuwan S. V., Webster C., Kyle H. K., Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. The American Journal of Tropical Medicine and Hygiene 1996 54 1 62 66 2-s2.0-0030023406
6. Ding X. C., Ubben D., Wells T. N., A framework for assessing the risk of resistance for anti-malarials in development. Malaria Journal 2012 11, article 292 10.1186/1475-2875-11-292 2-s2.0-84865176348
7. Anderson T. J. C., Nair S., Qin H., Singlam S., Brockman A., Paiphun L., Nosten F., Are transporter genes other than the chloroquine resistance locus (pfcrt) and multidrug resistance gene (pfmdr) associated with antimalarial drug resistance? Antimicrobial Agents and Chemotherapy 2005 49 6 2180 2188 10.1128/AAC.49.6.2180-2188.2005 2-s2.0-19544366088
8. Korsinczky M., Chen N., Kotecka B., Saul A., Rieckmann K., Cheng Q., Mutations in Plasmodium falciparum cytochrome b that are associated with atovaquone resistance are located at a putative drug-binding site. Antimicrobial Agents and Chemotherapy 2000 44 8 2100 2108 10.1128/AAC.44.8.2100-2108.2000 2-s2.0-0033931237
9. Peters J. M., Chen N., Gatton M., Korsinczky M., Fowler E. V., Manzetti S., Saul A., Cheng Q., Mutations in cytochrome b resulting in atovaquone resistance are associated with loss of fitness in Plasmodium falciparum. Antimicrobial Agents and Chemotherapy 2002 46 8 2435 2441 10.1128/AAC.46.8.2435-2441.2002 2-s2.0-0035991833
10. Garner P., Graves P. M., The benefits of artemisinin combination therapy for malaria extend beyond the individual patient. PLoS Medicine 2005 2 article e105 10.1371/journal.pmed.0020105 2-s2.0-19344375409
11. Shanks G. D., Treatment of falciparum malaria in the age of drug resistance. Journal of Postgraduate Medicine 2006 52 4 277 280 2-s2.0-33845274068
12. Santos G., Torres N. V., New targets for drug discovery against Malaria. PLoS ONE 2013 8 3 e59968 10.1371/journal.pone.0059968 2-s2.0-84875484319
13. Tse M. T., Antimalarial drugs: a treasure trove of potential antimalarials. Nature Reviews Drug Discovery 2010 9 7 516 517 10.1038/nrd3209 2-s2.0-77954223699
14. Molina D. M., Jafari R., Ignatushchenko M., Seki T., Larsson E. A., Dan C., Sreekumar L., Cao Y., Nordlund P., Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay. Science 2013 341 6141 84 87 10.1126/science.1233606 2-s2.0-84879748358
15. Dobson P. D., Lanthaler K., Oliver S. G., Kell D. B., Implications of the dominant role of transporters in drug uptake by cells. Current Topics in Medicinal Chemistry 2009 9 2 163 181 10.2174/156802609787521616 2-s2.0-63549100727
16. Djimdé A. D., Doumbo O. K., Cortese J. F., Kayentao K., Doumbo S., Diourté Y., Dicko A., Su X.-Z., Nomura T., Fidock D. A., Wellems T. E., Plowe C. V., Coulibaly D., A molecular marker for chloroquine-resistant falciparum malaria. The New England Journal of Medicine 2001 344 4 257 263 10.1056/NEJM200101253440403 2-s2.0-0035945682
17. Waller K. L., Muhle R. A., Ursos L. M., Horrocks P., Verdier-Pinard D., Sidhu A. B. S., Fujioka H., Roepe P. D., Fidock D. A., Chloroquine resistance modulated in vitro by expression levels of the Plasmodium falciparum chloroquine resistance transporter. Journal of Biological Chemistry 2003 278 35 33593 33601 10.1074/jbc.M302215200 2-s2.0-0041355267
18. Atroosh W. M., Al-Mekhlafi H. M., Mahdy M. A. K., Surin J., The detection of pfcrt and pfmdr1 point mutations as molecular markers of chloroquine drug resistance, Pahang, Malaysia. Malaria Journal 2012 11, article 251 10.1186/1475-2875-11-251 2-s2.0-84864398724
19. Dorsey G., Kamya M. R., Singh A., Rosenthal P. J., Polymorphisms in the Plasmodium falciparum pfcrt and pfmdr-1 genes and clinical response to chloroquine in Kampala, Uganda. Journal of Infectious Diseases 2001 183 9 1417 1420 10.1086/319865 2-s2.0-0035341936
20. Duraisingh M. T., Cowman A. F., Contribution of the pfmdr1 gene to antimalarial drug-resistance. Acta Tropica 2005 94 3 181 190 10.1016/j.actatropica.2005.04.008 2-s2.0-19344377032
21. Price R. N., Uhlemann A.-C., Brockman A., McGready R., Ashley E., Phaipun L., Patel R., Laing K., Looareesuwan S., White N. J., Nosten F., Krishna S., Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. The Lancet 2004 364 9432 438 447 10.1016/S0140-6736(04)16767-6 2-s2.0-2142769136
22. Rungsihirunrat K., Chaijareonkul W., Seugorn A., Na-Bangchang K., Thaithong S., Association between chloroquine resistance phenotypes and point mutations in pfcrt and pfmdr1 in Plasmodium falciparum isolates from Thailand. Acta Tropica 2009 109 1 37 40 10.1016/j.actatropica.2008.09.011 2-s2.0-56949096093
23. Andriantsoanirina V., Ratsimbasoa A., Bouchier C., Tichit M., Jahevitra M., Rabearimanana S., Raherinjafy R., Mercereau-Puijalon O., Durand R., Ménard D., Chloroquine clinical failures in P. falciparum malaria are associated with mutant Pfmdr-1, not Pfcrt in madagascar. PLoS ONE 2010 5 10 e13281 10.1371/journal.pone.0013281 2-s2.0-78149455663
24. Van Helvoort A., Smith A. J., Sprong H., Fritzsche I., Schinkel A. H., Borst P., Van Meer G., MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine. Cell 1996 87 3 507 517 10.1016/S0092-8674(00)81370-7 2-s2.0-0007544439
25. Sanchez C. P., Rotmann A., Stein W. D., Lanzer M., Polymorphisms within PfMDR1 alter the substrate specificity for anti-malarial drugs in Plasmodium falciparum. Molecular Microbiology 2008 70 4 786 798 10.1111/j.1365-2958.2008.06413.x 2-s2.0-54249123267
26. Rohrbach P., Sanchez C. P., Hayton K., Friedrich O., Patel J., Sidhu A. B. S., Ferdig M. T., Fidock D. A., Lanzer M., Genetic linkage of pfmdr1 with food vacuolar solute import in Plasmodium falciparum. The EMBO Journal 2006 25 13 3000 3011 10.1038/sj.emboj.7601203 2-s2.0-33746289507
27. von Seidlein L., Duraisingh M. T., Drakeley C. J., Bailey R., Greenwood B. M., Pinder M., Polymorphism of the Pfmdr1 gene and chloroquine resistance in Plasmodium falciparum in The Gambia. Transactions of the Royal Society of Tropical Medicine and Hygiene 1997 91 4 450 453 10.1016/S0035-9203(97)90281-9 2-s2.0-0030819934
28. Wilson C. M., Serrano A. E., Wasley A., Bogenschutz M. P., Shankar A. H., Wirth D. F., Amplification of a gene related to mammalian mdr genes in drug-resistant Plasmodium falciparum. Science 1989 244 4909 1184 1186 10.1126/science.2658061 2-s2.0-0024356582
29. Raj D. K., Mu J., Jiang H., Kabat J., Singh S., Sullivan M., Fay M. P., McCutchan T. F., Su X.-Z., Disruption of a Plasmodium falciparum multidrug resistance-associated protein (PfMRP) alters its fitness and transport of antimalarial drugs and glutathione. Journal of Biological Chemistry 2009 284 12 7687 7696 10.1074/jbc.M806944200 2-s2.0-65549119262
30. Rosenberg E., Litus I., Schwarzfuchs N., Sinay R., Schlesinger P., Golenser J., Baumeister S., Lingelbach K., Pollack Y., pfmdr2 confers heavy metal resistance to Plasmodium falciparum. Journal of Biological Chemistry 2006 281 37 27039 27045 10.1074/jbc.M601686200 2-s2.0-33748749415
31. Rubio J. P., Cowman A. F., Plasmodium faciparum: the pfmdr2 protein is not overexpressed in chloroquine-resistant isolates of the malaria parasite. Experimental Parasitology 1994 79 2 137 147 10.1006/expr.1994.1073 2-s2.0-0028169583
32. Briolant S., Henry M., Oeuvray C., Amalvict R., Baret E., Didillon E., Rogier C., Pradines B., Absence of association between piperaquine in vitro responses and polymorphisms in the pfcrt, pfmdr1, pfmrp, and pfnhe genes in Plasmodium falciparum. Antimicrobial Agents and Chemotherapy 2010 54 9 3537 3544 10.1128/AAC.00183-10 2-s2.0-77956155765
33. Póvoa M. M., Adagu I. S., Oliveira S. G., Machado R. L. D., Miles M. A., Warhurst D. C., Pfmdr1 (Asn)1042(ASp) and (Asp)1246(Tyr) polymorphisms, thought to be associated with chloroquine resistance, are present in chloroquine-resistant and -sensitive Brazilian field isolates of Plasmodium falciparum. Experimental Parasitology 1998 88 1 64 68 10.1006/expr.1998.4195 2-s2.0-0031608778
34. Duraisingh M. T., Drakeley C. J., Muller O., Bailey R., Snounou G., Targett G. A. T., Greenwood B. M., Warhurst D. C., Evidence for selection for the tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum by chloroquine and amodiaquine. Parasitology 1997 114 3 205 211 10.1017/S0031182096008487 2-s2.0-0030896558
35. Tinto H., Guekoun L., Zongo I., Guiguemdé R. T., D'Alessandro U., Ouédraogo J. B., Chloroquine-resistance molecular markers (Pfcrt T76 and Pfmdr-1 Y86) and amodiaquine resistance in Burkina Faso. Tropical Medicine and International Health 2008 13 2 238 240 10.1111/j.1365-3156.2007.01995.x 2-s2.0-39849083920
36. Barrett G. C., Chemistry and Biochemistry of the Amino Acids 1985 Amsterdam, The Netherlands Springer
37. Bray P. G., Hawley S. R., Mungthin M., Ward S. A., Physicochemical properties correlated with drug resistance and the reversal of drug resistance in Plasmodium falciparum. Molecular Pharmacology 1996 50 6 1559 1566 2-s2.0-0030451452
38. Babiker H. A., Pringle S. J., Abdel-Muhsin A., Mackinnon M., Hunt P., Walliker D., High-level chloroquine resistance in Sudanese isolates of Plasmodium falciparum is associated with mutations in the chloroquine resistance transporter gene pfcrt and the multidrug resistance gene pfmdr1. Journal of Infectious Diseases 2001 183 10 1535 1538 10.1086/320195 2-s2.0-0035873715
39. Haruki K., Bray P. G., Ward S. A., Hommel M., Ritchie G. Y., Chloroquine resistance of Plasmodium falciparum: further evidence for a lack of association with mutations of the pfmdr1 gene. Transactions of the Royal Society of Tropical Medicine and Hygiene 1994 88 6 694 10.1016/0035-9203(94)90234-8 2-s2.0-0028609975
40. Wellems T. E., Panton L. J., Gluzman I. Y., Do Rosario V. E., Gwadz R. W., Walker-Jonah A., Krogstad D. J., Chloroquine resistance not linked to mdr-like genes in Plasmodium falciparum cross. Nature 1990 345 6272 253 255 10.1038/345253a0 2-s2.0-0025305350
41. Basco L. K., Bras J. L., Rhoades Z., Wilson C. M., Analysis of pfmdr1 and drug susceptibility in fresh isolates of Plasmodium falciparum from Subsaharan Africa. Molecular and Biochemical Parasitology 1995 74 2 157 166 10.1016/0166-6851(95)02492-1 2-s2.0-0029586497
42. Foote S. J., Kyle D. E., Martin R. K., Oduola A. M. J., Forsyth K., Kemp D. J., Cowman A. F., Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum. Nature 1990 345 6272 255 258 10.1038/345255a0 2-s2.0-0025269612
43. Basco L. K., Ringwald P., Molecular epidemiology of malaria in Yaounde, Cameroon. III. Analysis of chloroquine resistance and point mutations in the multidrug resistance 1 (pfmdr 1) gene of Plasmodium falciparum. The American Journal of Tropical Medicine and Hygiene 1998 59 4 577 581 2-s2.0-0031724298
44. McCutcheon K. R. G., Freese J. A., Frean J. A., Sharp B. L., Markus M. B., Two mutations in the multidrug-resistance gene homologue of Plasmodium falciparum, pfmdr1, are not useful predictors of in-vivo or in-vitro chloroquine resistance in southern Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene 1999 93 3 300 302 10.1016/S0035-9203(99)90029-9 2-s2.0-0032784122
45. Mungthin M., Intanakom S., Suwandittakul N., Suida P., Amsakul S., Sitthichot N., Thammapalo S., Leelayoova S., Distribution of pfmdr1 polymorphisms in Plasmodium falciparum isolated from Southern Thailand. Malaria Journal 2014 13 1, article 117 10.1186/1475-2875-13-117 2-s2.0-84899129486
46. Reed M. B., Saliba K. J., Caruana S. R., Kirk K., Cowman A. F., Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature 2000 403 6772 906 909 10.1038/35002615 2-s2.0-0034708162
47. Griffin C. E., Hoke J. M., Samarakoon U., Duan J., Mu J., Ferdig M. T., Warhurst D. C., Cooper R. A., Mutation in the Plasmodium falciparum CRT protein determines the stereospecific activity of antimalarial Cinchona alkaloids. Antimicrobial Agents and Chemotherapy 2012 56 10 5356 5364 10.1128/AAC.05667-11 2-s2.0-84866340548
48. Reed M. B., Saliba K. J., Caruana S. R., Kirk K., Cowman A. F., Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature 2000 403 6772 906 909 10.1038/35002615 2-s2.0-0034708162
49. Ritchie G. Y., Mungthin M., Green J. E., Bray P. G., Hawley S. R., Ward S. A., In vitro selection of halofantrine resistance in Plasmodium falciparum is not associated with increased expression of Pgh1. Molecular and Biochemical Parasitology 1996 83 1 35 46 10.1016/S0166-6851(96)02746-6 2-s2.0-0030566669
50. Chavchich M., Gerena L., Peters J., Chen N., Cheng Q., Kyle D. E., Role of pfmdr1 amplification and expression in induction of resistance to artemisinin derivatives in Plasmodium falciparum. Antimicrobial Agents and Chemotherapy 2010 54 6 2455 2464 10.1128/AAC.00947-09 2-s2.0-77952664258
51. Mu J., Ferdig M. T., Feng X., Joy D. A., Duan J., Furuya T., Subramanian G., Aravind L., Cooper R. A., Wootton J. C., Xiong M., Su X.-Z., Multiple transporters associated with malaria parasite responses to chloroquine and quinine. Molecular Microbiology 2003 49 4 977 989 10.1046/j.1365-2958.2003.03627.x 2-s2.0-10744231302
52. Zhang H., Howard E. M., Roepe P. D., Analysis of the antimalarial drug resistance protein Pfcrt expressed in yeast. Journal of Biological Chemistry 2002 277 51 49767 49775 10.1074/jbc.M204005200 2-s2.0-0037147244
53. Singh Sidhu A. B., Verdier-Pinard D., Fidock D. A., Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations. Science 2002 298 5591 210 213 10.1126/science.1074045 2-s2.0-0037020024
54. Valderramos S. G., Valderramos J. C., Musset L., Purcell L. A., Mercereau-Puijalon O., Legrand E., Fidock D. A., Identification of a mutant PfCRT-mediated chloroquine tolerance phenotype in Plasmodium falciparum. PLoS pathogens 2010 6 5 e1000887 2-s2.0-77955969087
55. Awasthi G., Das A., Genetics of chloroquine-resistant malaria: a haplotypic view. Memórias do Instituto Oswaldo Cruz 2013 108 8 947 961 10.1590/0074-0276130274 2-s2.0-84890353889
56. Kolippakkam V. S. M. A. D., Amino acid physicochemical properties database. Bioinformation 2005 1 1 2 4
57. Antosiewicz J., McCammon J. A., Gilson M. K., Prediction of pH-dependent properties of proteins. Journal of Molecular Biology 1994 238 3 415 436 10.1006/jmbi.1994.1301 2-s2.0-0028305457
58. Chen N., Kyle D. E., Pasay C., Fowler E. V., Baker J., Peters J. M., Cheng Q., Pfcrt allelic types with two novel amino acid mutations in chloroquine-resistant Plasmodium falciparum isolates from the Philippines. Antimicrobial Agents and Chemotherapy 2003 47 11 3500 3505 10.1128/AAC.47.11.3500-3505.2003 2-s2.0-0242290995
59. Lakshmanan V., Bray P. G., Verdier-Pinard D., Johnson D. J., Horrocks P., Muhle R. A., Alakpa G. E., Hughes R. H., Ward S. A., Krogstad D. J., Sidhu A. B. S., Fidock D. A., A critical role for PfCRT K76T in Plasmodium falciparum verapamil-reversible chloroquine resistance. EMBO Journal 2005 24 13 2294 2305 10.1038/sj.emboj.7600681 2-s2.0-22744447610
60. Umar R. A. H., Hassan S. W., Ladan M. J., Nma Jiya M., Abubakar M. K., Nata'ala U., The association of K76T mutation in Pfcrt gene and chloroquine treatment failure in uncomplicated Plasmodium falciparum malaria in a cohort of Nigerian children. Journal of Applied Sciences 2007 7 23 3696 3704 10.3923/jas.2007.3696.3704 2-s2.0-37349085396
61. Evans S. G., Havlik I., In vitro drug interaction between amantadine and classical antimalarial drugs in Plasmodium falciparum infections. Transactions of the Royal Society of Tropical Medicine and Hygiene 1994 88 6 683 686 10.1016/0035-9203(94)90229-1 2-s2.0-0028610517
62. Cooper R. A., Ferdig M. T., Su X.-Z., Ursos L. M. B., Mu J., Nomura T., Fujioka H., Fidock D. A., Roepe P. D., Wellems T. E., Alternative mutations at position 76 of the vacuolar transmembrane protein PfCRT are associated with chloroquine resistance and unique stereospecific quinine and quinidine responses in Plasmodium falciparum. Molecular Pharmacology 2002 61 1 35 42 10.1124/mol.61.1.35 2-s2.0-18244396971
63. Bayoumi R. A., Babiker H. A., Ibrahim S. M., Ghalib H. W., Saeed B. O., Khider S., Elwasila M., Karim E. A., Chloroquine-resistant Plasmodium falciparum in Eastern Sudan. Acta Tropica 1989 46 3 157 165 10.1016/0001-706X(89)90032-6 2-s2.0-0024840215
64. Travassos M. A., Laufer M. K., Resistance to antimalarial drugs: molecular, pharmacologic, and clinical considerations. Pediatric Research 2009 65 5, article 2 64R 70R 10.1203/PDR.0b013e3181a0977e 2-s2.0-68049140634
65. Keen J., Farcas G. A., Zhong K., Yohanna S., Dunne M. W., Kain K. C., Real-time PCR assay for rapid detection and analysis of PfCRT haplotypes of chloroquine-resistant Plasmodium falciparum isolates from India. Journal of Clinical Microbiology 2007 45 9 2889 2893 10.1128/JCM.02291-06 2-s2.0-34548671820
66. Awasthi G., Satya G. B. K., Das A., Pfcrt haplotypes and the evolutionary history of chloroquine-resistant Plasmodium falciparum. Memórias do Instituto Oswaldo Cruz 2012 107 1 129 134 10.1590/S0074-02762012000100018 2-s2.0-84857089282
67. Mehlotra R. K., Fujioka H., Roepe P. D., Janneh O., Ursos L. M. B., Jacobs-Lorena V., McNamara D. T., Bockarie M. J., Kazura J. W., Kyle D. E., Fidock D. A., Zimmerman P. A., Evolution of a unique Plasmodium falciparum chloroquine-resistance phenotype in association with pfcrt polymorphism in Papua New Guinea and South America. Proceedings of the National Academy of Sciences of the United States of America 2001 98 22 12689 12694 10.1073/pnas.221440898 2-s2.0-0035940425
68. Valderramos S. G., Fidock D. A., Transporters involved in resistance to antimalarial drugs. Trends in Pharmacological Sciences 2006 27 11 594 601 10.1016/j.tips.2006.09.005 2-s2.0-33749989605
69. Vieira P. P., Ferreira M. U., Alecrim M. D. G., Alecrim W. D., Da Silva L. H. P., Sihuincha M. M., Joy D. A., Mu J., Su X.-Z., Zalis M. G., pfcrt polymorphism and the spread of chloroquine resistance in Plasmodium falciparum populations across the Amazon Basin. Journal of Infectious Diseases 2004 190 2 417 424 10.1086/422006 2-s2.0-3242671257
70. Bennett T. N., Kosar A. D., Ursos L. M. B., Dzekunov S., Sidhu A. B. S., Fidock D. A., Roepe P. D., Drug resistance-associated pfCRT mutations confer decreased Plasmodium falciparum digestive vacuolar pH. Molecular and Biochemical Parasitology 2004 133 1 99 114 10.1016/j.molbiopara.2003.09.008 2-s2.0-0345528107
71. Sidhu A. B. S., Verdier-Pinard D., Fidock D. A., Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations. Science 2002 298 5591 210 213 10.1126/science.1074045 2-s2.0-0037020024
72. Jiang H., Li N., Gopalan V., Zilversmit M. M., Varma S., Nagarajan V., Li J., Mu J., Hayton K., Henschen B., Yi M., Stephens R., McVean G., Awadalla P., Wellems T. E., Su X.-Z., High recombination rates and hotspots in a Plasmodium falciparum genetic cross. Genome Biology 2011 12 4, article R33 10.1186/gb-2011-12-4-r33 2-s2.0-79953261109
73. Mita T., Kaneko A., Hombhanje F., Hwaihwanje I., Takahashi N., Osawa H., Tsukahara T., Masta A., Lum J. K., Kobayakawa T., Ishizaki T., Björkman A., Role of pfmdr1 mutations on chloroquine resistance in Plasmodium falciparum isolates with pfcrt K76T from Papua New Guinea. Acta Tropica 2006 98 2 137 144 10.1016/j.actatropica.2006.03.002 2-s2.0-33646883694
74. Papakrivos J., Sá J. M., Wellems T. E., Functional characterization of the Plasmodium falciparum chloroquine-resistance transporter (PfCRT) in transformed Dictyostelium discoideum vesicles. PLoS ONE 2012 7 6 e39569 10.1371/journal.pone.0039569 2-s2.0-84862546179
75. +-ATPase. The Journal of Biological Chemistry 1999 274 47 33213 33219 10.1074/jbc.274.47.33213 2-s2.0-0033584993
76. +-pyrophosphatase. Journal of Biological Chemistry 2003 278 8 5605 5612 10.1074/jbc.M208648200 2-s2.0-0037458576
77. Lehane A. M., Kirk K., Chloroquine resistance-conferring mutations in pfcrt give rise to a chloroquine-associated H+ leak from the malaria parasite's digestive vacuole. Antimicrobial Agents and Chemotherapy 2008 52 12 4374 4380 10.1128/AAC.00666-08 2-s2.0-57049091831
78. Lehane A. M., Hayward R., Saliba K. J., Kirk K., A verapamil-sensitive chloroquine-associated H+ leak from the digestive vacuole in chloroquine-resistant malaria parasites. Journal of Cell Science 2008 121 10 1624 1632 10.1242/jcs.016758 2-s2.0-46249086673
79. Henry M., Alibert S., Orlandi-Pradines E., Bogreau H., Fusai T., Rogier C., Barbe J., Pradines B., Chloroquine resistance reversal agents as promising antimalarial drugs. Current Drug Targets 2006 7 8 935 948 10.2174/138945006778019372 2-s2.0-33747151908
80. Warhurst D. C., Polymorphism in the Plasmodium falciparum chloroquine-resistance transporter protein links verapamil enhancement of chloroquine sensitivity with the clinical efficacy of amodiaquine. Malaria Journal 2003 2, article 31 2-s2.0-1542650643
81. Amodu O. K., Hartl D. L., Roy S. W., Patterns of polymorphism in genomic regions flanking three highly polymorphic surface antigens in Plasmodium falciparum. Molecular and Biochemical Parasitology 2008 159 1 1 6 10.1016/j.molbiopara.2007.12.004 2-s2.0-41549147751
82. Evans S. G., Havlik I., Plasmodium falciparum: effects of amantadine, an antiviral, on chloroquine-resistant and -sensitive parasites in vitro and its influence on chloroquine activity. Biochemical Pharmacology 1993 45 5 1168 1170 10.1016/0006-2952(93)90264-W 2-s2.0-0027537374
83. Hay S. I., Guerra C. A., Tatem A. J., Noor A. M., Snow R. W., The global distribution and population at risk of malaria: past, present, and future. Lancet Infectious Diseases 2004 4 6 327 336 10.1016/S1473-3099(04)01043-6 2-s2.0-2542451884
84. Kelly M. L., Cook J. A., Brown-Augsburger P., Heinz B. A., Smith M. C., Pinto L. H., Demonstrating the intrinsic ion channel activity of virally encoded proteins. FEBS Letters 2003 552 1 61 67 10.1016/S0014-5793(03)00851-2 2-s2.0-0041834450
85. Le Bras J., Durand R., The mechanisms of resistance to antimalarial drugs in Plasmodium falciparum. Fundamental and Clinical Pharmacology 2003 17 2 147 153 10.1046/j.1472-8206.2003.00164.x 2-s2.0-0037396367
86. Bray P. G., Ward S. A., A comparison of the phenomenology and genetics of multidrug resistance in cancer cells and quinoline resistance in Plasmodium falciparum. Pharmacology and Therapeutics 1998 77 1 1 28 10.1016/S0163-7258(97)00083-1 2-s2.0-0031964307
87. Johnson D. J., Fidock D. A., Mungthin M., Lakshmanan V., Sidhu A. B. S., Bray P. G., Ward S. A., Evidence for a central role for PfCRT in conferring Plasmodium falciparum resistance to diverse antimalarial agents. Molecular Cell 2004 15 6 867 877 10.1016/j.molcel.2004.09.012 2-s2.0-4644251136
88. Wooden J., Gould E. E., Paull A. T., Sibley C. H., Plasmodium falciparum: a simple polymerase chain reaction method for differentiating strains. Experimental Parasitology 1992 75 2 207 212 10.1016/0014-4894(92)90180-I 2-s2.0-0026917894
89. Bray P. G., Janneh O., Raynes K. J., Mungthin M., Ginsburg H., Ward S. A., Cellular uptake of chloroquine is dependent on binding to ferriprotoporphyrin IX and is independent of NHE activity in Plasmodium falciparum. Journal of Cell Biology 2000 145 2 363 376 10.1083/jcb.145.2.363 2-s2.0-0344867895
90. Peel S. A., Merritt S. C., Handy J., Baric R. S., Derivation of highly mefloquine-resistant lines from Plasmodium falciparum in vitro. American Journal of Tropical Medicine and Hygiene 1993 48 3 385 397 2-s2.0-0027474443
91. Peel S. A., Bright P., Yount B., Handy J., Baric R. S., A strong association between mefloquine and halofantrine resistance and amplification, overexpression, and mutation in the P-glycoprotein gene homolog (pfmdr) of Plasmodium falciparum in vitro. The American Journal of Tropical Medicine and Hygiene 1994 51 5 648 658 2-s2.0-0028135205
92. Lim P., Chy S., Ariey F., Incardona S., Chim P., Sem R., Denis M. B., Hewitt S., Hoyer S., Socheat D., Merecreau-Puijalon O., Fandeur T., pfcrt polymorphism and chloroquine resistance in Plasmodium falciparum strains isolated in Cambodia. Antimicrobial Agents and Chemotherapy 2003 47 1 87 94 10.1128/AAC.47.1.87-94.2003 2-s2.0-12244269105
93. Lefèvre G., Looareesuwan S., Treeprasertsuk S., Krudsood S., Silachamroon U., Gathmann I., Mull R., Bakshi R., A clinical and pharmacokinetic trial of six doses of artemether-lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand. The American Journal of Tropical Medicine and Hygiene 2001 64 5 247 256 2-s2.0-0034946077
94. Nateghpour M., Ward S. A., Howells R. E., Development of halofantrine resistance and determination of cross- resistance patterns in Plasmodium falciparum. Antimicrobial Agents and Chemotherapy 1993 37 11 2337 2343 10.1128/AAC.37.11.2337 2-s2.0-0027430887
95. Mwai L., Kiara S. M., Abdirahman A., Pole L., Rippert A., Diriye A., Bull P., Marsh K., Borrmann S., Nzila A., In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1. Antimicrobial Agents and Chemotherapy 2009 53 12 5069 5073 10.1128/AAC.00638-09 2-s2.0-71249142664
96. Mwai L., Diriye A., Masseno V., Muriithi S., Feltwell T., Musyoki J., Lemieux J., Feller A., Mair G. R., Marsh K., Newbold C., Nzila A., Carret C. K., Genome wide adaptations of Plasmodium falciparum in response to Lumefantrine selective drug pressure. PLoS ONE 2012 7 2 e31623 10.1371/journal.pone.0031623 2-s2.0-84857584901
97. Andriantsoanirina V., Ratsimbasoa A., Bouchier C., Jahevitra M., Rabearimanana S., Radrianjafy R., Andrianaranjaka V., Randriantsoa T., Rason M. A., Tichit M., Rabarijaona L. P., Mercereau-Puijalon O., Durand R., Ménard D., Plasmodium falciparum drug resistance in Madagascar: facing the spread of unusual pfdhfr and pfmdr-1 haplotypes and the decrease of dihydroartemisinin susceptibility. Antimicrobial Agents and Chemotherapy 2009 53 11 4588 4597 10.1128/AAC.00610-09 2-s2.0-70350267053
98. Griffin C. E., Hoke J. M., Samarakoon U., Duan J., Mu J., Ferdig M. T., Warhurst D. C., Cooper R. A., Mutation in the Plasmodium falciparum CRT protein determines the stereospecific activity of antimalarial Cinchona alkaloids. Antimicrobial Agents and Chemotherapy 2012 56 10 5356 5364 10.1128/AAC.05667-11 2-s2.0-84866340548
99. Sá J. M., Twu O., Hayton K., Reyes S., Fay M. P., Ringwald P., Wellems T. E., Geographic patterns of Plasmodium falciparum drug resistance distinguished by differential responses to amodiaquine and chloroquine. Proceedings of the National Academy of Sciences of the United States of America 2009 106 45 18883 18889 10.1073/pnas.0911317106 2-s2.0-73149118025